01—Abstract
Summary
Summary of the 8-K filed September 9, 2024. Cited figures are marked; the original filing is the authoritative source.
Cardinal Health, Inc. (CAH) filed an 8-K report announcing the decision of two Board of Directors members, Steven K.
Barg and Sujatha Chandrasekaran, not to stand for re-election at the upcoming 2024 annual shareholder meeting. Both directors, who joined the board in 2022 as part of a cooperation agreement with Elliott Associates, will continue their service until the meeting concludes. Their departure is stated to be unrelated to any disagreements with the company's operations or policies.
Mr. Barg served on the now-sunsetted Business Review Committee and currently sits on the Governance and Sustainability Committee, while Ms. Chandrasekaran is a member of the Audit and Risk Oversight Committees. The company expressed gratitude for their contributions during their tenure.
02—Key points
Key Highlights
- Two Board of Directors members, Steven K. Barg and Sujatha Chandrasekaran, will not seek re-election at the 2024 annual shareholder meeting.
- Both directors were appointed in 2022 as part of a cooperation agreement with Elliott Associates.
- Their decisions to not stand for re-election are not due to any disagreements with Cardinal Health's operations, policies, or practices.
- Mr. Barg was part of the Business Review Committee and currently serves on the Governance and Sustainability Committee.
- Ms. Chandrasekaran serves on the Audit and Risk Oversight Committees.
- Both directors will continue to serve until the 2024 annual shareholder meeting.
- The company thanked both directors for their service and contributions.
03—Questions
Frequently Asked Questions
Why are Steven K. Barg and Sujatha Chandrasekaran not standing for re-election?
According to the filing, both Mr. Barg and Ms. Chandrasekaran have independently decided not to stand for re-election when their terms expire. They have indicated that their decisions are not the result of any disagreement with the company's operations, policies, or practices.
Will these directors be leaving the board immediately?
No, both Mr. Barg and Ms. Chandrasekaran will continue to serve as directors until the 2024 annual meeting of shareholders.
What was the significance of their appointment to the board?
Both directors were originally appointed to the Board as investor designees pursuant to a cooperation agreement entered into in September 2022 between Cardinal Health and Elliott Associates, L.P. and Elliott International, L.P. This suggests their initial appointments were related to shareholder engagement and strategic oversight.
What committees were these directors involved in?
Mr. Barg was a member of the Business Review Committee (which has since sunsetted) and currently serves on the Governance and Sustainability Committee. Ms. Chandrasekaran is a member of the Audit and Risk Oversight Committees.
04—Continue